2003
DOI: 10.1080/713606703
|View full text |Cite
|
Sign up to set email alerts
|

Transient gestational diabetes insipidus: report of two cases and review of pathophysiology and treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 0 publications
0
4
0
1
Order By: Relevance
“…GDI is a self‐limiting condition that usually resolves within the first few weeks post‐partum. The treatment of choice is 1‐desamino‐8‐D‐arginine vasopressin (DDAVP), a synthetic analogue of vasopressin, which is resistant to degradation by vasopressinase, unlike ADH . DDAVP selectively activates the nonpressor V2 receptor, thus avoiding stimulation of blood pressure or uterine contractions, and is relatively long‐acting (12 h).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…GDI is a self‐limiting condition that usually resolves within the first few weeks post‐partum. The treatment of choice is 1‐desamino‐8‐D‐arginine vasopressin (DDAVP), a synthetic analogue of vasopressin, which is resistant to degradation by vasopressinase, unlike ADH . DDAVP selectively activates the nonpressor V2 receptor, thus avoiding stimulation of blood pressure or uterine contractions, and is relatively long‐acting (12 h).…”
Section: Discussionmentioning
confidence: 99%
“…Gestational diabetes insipidus (GDI) complicates about 4 out of 100,000 pregnancies . This disorder is believed to be related to excess vasopressinase activity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…11 Some of these changes include an increase in cardiac output and glomerular filtration rate, sodium and water retention leading to blood volume expansion, chronic respiratory alkalosis, hyponatremia, and a reduction in systemic vascular resistance and blood pressure. They reach their peak during the second trimester, remain relatively stable during the third trimester, and rapidly reverse after delivery.…”
Section: Discussionmentioning
confidence: 99%
“…Die Therapie der Wahl ist 1-Desamino-8-D-Arginin-Vasopressin (DDAVP), ein synthetisches Analogon von Vasopressin, das resistent auf den Abbau durch Vasopressinase ist [8]. Das DDAVP kann in mehreren Formen appliziert werden, aber die intranasale Applikation wirdwegen ihrer guten Dosierbarkeitam häufigsten genutzt, da eine DDAVP-Überdosierung leicht zu Hyponatriämie führen kann [7].…”
Section: Diskussionunclassified